Year: 2025
Type: article
Abstract: Conclusion: Low-dose infliximab may be an effective and safe adjunctive
Authors: Miss Anna Szabó, Dr. Zsófia Lanszki, Dr. Gábor Kemenesi, Dr. Endre Sós, Miss Ágnes Nagy, Dr. Éva Szűts, Dr. Tamás Görföl
Institution: University of Pecs
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,900
OpenAlex ID: W4408046612